Medipattern has recently signed an agreement with GE Healthcare to create a set of image quantification tools to help physicians visualize plaque and other conditions that can block the vascular system.
Jeff Collins, CEO of The Medipattern, said: Under the agreement with GE Healthcare, GE and Medipattern have been working on a proof of concept for the vascular quantification tool that we shared with Bob Kane and his colleagues at Navix.
GE Healthcare’s Vascular Ultrasound team is committed to developing new technology to image and analyze vascular disease, increasing diagnostic confidence and speeding patient treatment.
Medipattern recently announced an agreement with GE Healthcare to create a set of image quantification tools to help physicians visualize plaque and other conditions that can block the vascular system.
Navix Diagnostix is a privately held company, which provides cardiovascular management solutions for hospitals and medical practices.
Medipattern is a pharmaceutical company, which focuses on the development of medical software solutions that help improve imaging workflow and productivity. Medipattern uses its Cadenza(TM) CAD Technology to power the digital conversion in medical communications.